Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions
暂无分享,去创建一个
Jochen Keupp | Samuel A. Wickline | Anne H. Schmieder | Shelton D. Caruthers | Gregory M. Lanza | S. Caruthers | A. Schmieder | S. Wickline | G. Lanza | J. Keupp
[1] B. A. French,et al. Early Assessment of Pulmonary Inflammation by 19F MRI In Vivo , 2010, Circulation. Cardiovascular imaging.
[2] H. Hummler,et al. Partial liquid ventilation in severely surfactant-depleted, spontaneously breathing rabbits supported by proportional assist ventilation , 2001, Critical care medicine.
[3] Hisaaki Ochi,et al. Double-tuned radiofrequency coil for (19)F and (1)H imaging. , 2014, Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine.
[4] C H Lorenz,et al. Enhanced detection of thrombi with a novel fibrin-targeted magnetic resonance imaging agent. , 1998, Academic radiology.
[5] Stasia A. Anderson,et al. Magnetic resonance contrast enhancement of neovasculature with αvβ3‐targeted nanoparticles , 2000 .
[6] M. Krafft,et al. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. , 2001, Advanced drug delivery reviews.
[7] B B Gosink,et al. Perfluoroctylbromide: a liver/spleen-specific and tumor-imaging ultrasound contrast material. , 1982, Radiology.
[8] J. Bulte,et al. Gene expression profiling reveals early cellular responses to intracellular magnetic labeling with superparamagnetic iron oxide nanoparticles , 2010, Magnetic resonance in medicine.
[9] Samuel A. Wickline,et al. Molecular Imaging of Angiogenesis in Early-Stage Atherosclerosis With &agr;v&bgr;3-Integrin–Targeted Nanoparticles , 2003 .
[10] Tobias Schaeffter,et al. Simultaneous 19 F and 1 H imaging on a clinical 3T MR scanner , 2006 .
[11] S A Wickline,et al. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. , 2007, Nanomedicine.
[12] Sheng-Kwei Song,et al. High‐resolution MRI characterization of human thrombus using a novel fibrin‐targeted paramagnetic nanoparticle contrast agent , 2000, Magnetic resonance in medicine.
[13] M. Malet‐Martino,et al. Fluorine-19 or phosphorus-31 NMR spectroscopy: a suitable analytical technique for quantitative in vitro metabolic studies of fluorinated or phosphorylated drugs. , 2005, Journal of pharmaceutical and biomedical analysis.
[14] P M Joseph,et al. Fluorinated blood substitute retention in the rat measured by fluorine-19 magnetic resonance imaging. , 1992, Investigative radiology.
[15] Matthias Stuber,et al. Positive contrast visualization of iron oxide‐labeled stem cells using inversion‐recovery with ON‐resonant water suppression (IRON) , 2007, Magnetic resonance in medicine.
[16] Samuel A Wickline,et al. Exploiting lipid raft transport with membrane targeted nanoparticles: a strategy for cytosolic drug delivery. , 2008, Biomaterials.
[17] P. Murphy,et al. Fluorine magnetic resonance in vivo: a powerful tool in the study of drug distribution and metabolism. , 2008, Drug discovery today.
[18] C. Higgins,et al. Perfluoroctylbromide. Acute hemodynamic effects, in pigs, of intravenous administration compared with the standard ionic contrast media. , 1984, Investigative radiology.
[19] N. Simpson,et al. Dual perfluorocarbon method to noninvasively monitor dissolved oxygen concentration in tissue engineered constructs in vitro and in vivo , 2011, Biotechnology progress.
[20] J. Martin,et al. Perfluorochemicals as gastrointestinal contrast agents for MR imaging: preliminary studies in rats and humans. , 1987, AJR. American journal of roentgenology.
[21] W. Mitzner,et al. Angiogenesis in the mouse lung. , 2000, The American journal of pathology.
[22] K. Scheffler,et al. Principles and applications of balanced SSFP techniques , 2003, European Radiology.
[23] D. Le Bihan,et al. A new paradigm for high‐sensitivity 19F magnetic resonance imaging of perfluorooctylbromide , 2010, Magnetic resonance in medicine.
[24] S. Caruthers,et al. 19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeacons , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[25] C. Higgins,et al. Perfluoroctylbromide: a reticuloendothelial-specific and tumor-imaging agent for computed tomography. , 1982, Radiology.
[26] S. Caruthers,et al. Dual Resolution Simultaneous 19 F / 1 H In Vivo Imaging of Targeted Nanoparticles , 2008 .
[27] Enzo Terreno,et al. Tunable imaging of cells labeled with MRI-PARACEST agents. , 2005, Angewandte Chemie.
[28] K. Shastri,et al. Complement activation by artificial blood substitute Fluosol: in vitro and in vivo studies , 1991, Transfusion.
[29] Enzo Terreno,et al. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. , 2005, Angewandte Chemie.
[30] P. Antich,et al. Perfluorocarbon imaging in vivo: a 19F MRI study in tumor-bearing mice. , 1989, Magnetic resonance imaging.
[31] Robert E Lenkinski,et al. pCEST: Positive contrast using Chemical Exchange Saturation Transfer. , 2012, Journal of magnetic resonance.
[32] Kerry K. Karukstis,et al. Targeted Antiproliferative Drug Delivery to Vascular Smooth Muscle Cells With a Magnetic Resonance Imaging Nanoparticle Contrast Agent: Implications for Rational Therapy of Restenosis , 2002, Circulation.
[33] Patrick J. Gaffney,et al. Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted 19F nanoparticles , 2004 .
[34] N. Gavriely,et al. Perfluorocarbon induced alterations in pulmonary mechanics. , 1998, Artificial cells, blood substitutes, and immobilization biotechnology.
[35] S. Cain,et al. Effect of continuous rotation on the efficacy of partial liquid (perflubron) breathing in canine acute lung injury. , 1994, Advances in experimental medicine and biology.
[36] E. Terreno,et al. First ex-vivo MRI co-localization of two LIPOCEST agents. , 2008, Contrast media & molecular imaging.
[37] P A Bottomley,et al. Human in vivo NMR spectroscopy in diagnostic medicine: clinical tool or research probe? , 1989, Radiology.
[38] Jinming Gao,et al. In vivo off-resonance saturation magnetic resonance imaging of alphavbeta3-targeted superparamagnetic nanoparticles. , 2009, Cancer research.
[39] J. Bulte,et al. Tagging of T cells with superparamagnetic iron oxide: uptake kinetics and relaxometry. , 1996, Academic radiology.
[40] Eric T Ahrens,et al. Combining perfluorocarbon and superparamagnetic iron‐oxide cell labeling for improved and expanded applications of cellular MRI , 2015, Magnetic resonance in medicine.
[41] Enzo Terreno,et al. Gadolinium-doped LipoCEST agents: a potential novel class of dual 1H-MRI probes. , 2011, Chemical communications.
[42] E. Ahrens,et al. A novel 19F agent for detection and quantification of human dendritic cells using magnetic resonance imaging , 2011, International journal of cancer.
[43] S. Aime,et al. MRI CEST at 1T with large µeff Ln3+ complexes T m3+‐HPDO3A: An efficient MRI pH reporter , 2016, Magnetic resonance in medicine.
[44] S. Caruthers,et al. High Sensitivity: High-Resolution SPECT-CT/MR Molecular Imaging of Angiogenesis in the Vx2 Model , 2009, Investigative radiology.
[45] A. Sambanis,et al. In vivo noninvasive monitoring of dissolved oxygen concentration within an implanted tissue-engineered pancreatic construct. , 2011, Tissue engineering. Part C, Methods.
[46] Peter Börnert,et al. Three‐dimensional radial ultrashort echo‐time imaging with T2 adapted sampling , 2006, Magnetic resonance in medicine.
[47] S. Bott,et al. Synthesis, relaxometric and photophysical properties of a new pH-responsive MRI contrast agent: the effect of other ligating groups on dissociation of a p-nitrophenolic pendant arm. , 2004, Journal of the American Chemical Society.
[48] P. Bachert. PHARMACOKINETICS USING FLUORINE NMR IN VIVO , 1998 .
[49] Jiadi Xu,et al. Multi‐echo Length and Offset VARied Saturation (MeLOVARS) method for improved CEST imaging , 2015, Magnetic resonance in medicine.
[50] K. Nicolay,et al. Relaxometric studies of gadolinium-functionalized perfluorocarbon nanoparticles for MR imaging. , 2014, Contrast media & molecular imaging.
[51] Nirbhay N. Yadav,et al. Single 19F Probe for Simultaneous Detection of Multiple Metal Ions Using miCEST MRI , 2014, Journal of the American Chemical Society.
[52] Qing Ye,et al. 19F MRI detection of acute allograft rejection with in vivo perfluorocarbon labeling of immune cells , 2011, Magnetic resonance in medicine.
[53] K. Lowe. Perfluorinated blood substitutes and artificial oxygen carriers. , 1999, Blood reviews.
[54] A. Kassner,et al. Molecular Imaging of Angiogenesis in Nascent Vx-2 Rabbit Tumors Using a Novel ανβ3-targeted Nanoparticle and 1.5 Tesla Magnetic Resonance Imaging , 2003 .
[55] S. Wickline,et al. αvβ3–Targeted nanotherapy suppresses inflammatory arthritis in mice , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[56] J. Hampton,et al. An electron microscope study of the hepatic uptake and excretion of submicroscopic particles injected into the blood stream and into the bile duct. , 1958, Acta anatomica.
[57] S. Caruthers,et al. Theragnostics for tumor and plaque angiogenesis with perfluorocarbon nanoemulsions , 2010, Angiogenesis.
[58] Kilian Q. Weinberger,et al. Physicochemical signatures of nanoparticle-dependent complement activation. , 2014, Computational science & discovery.
[59] D. Ballon,et al. A 64 MHz half-birdcage resonator for clinical imaging , 1990 .
[60] Samuel A Wickline,et al. Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI/MRS , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[61] A. Sherry,et al. Structural and chiroptical properties of the two coordination isomers of YbDOTA-type complexes. , 2005, Inorganic chemistry.
[62] J. Bulte,et al. Size-induced enhancement of chemical exchange saturation transfer (CEST) contrast in liposomes. , 2008, Journal of the American Chemical Society.
[63] S. Caruthers,et al. Synergy between surface and core entrapped metals in a mixed manganese-gadolinium nanocolloid affords safer MR imaging of sparse biomarkers. , 2015, Nanomedicine : nanotechnology, biology, and medicine.
[64] Peter C M van Zijl,et al. Sensitive CEST agents based on nucleic acid imino proton exchange: Detection of poly(rU) and of a dendrimer‐poly(rU) model for nucleic acid delivery and pharmacology , 2003, Magnetic resonance in medicine.
[65] Cornelius Faber,et al. Boosting 19F MRI—SNR efficient detection of paramagnetic contrast agents using ultrafast sequences , 2013, Magnetic resonance in medicine.
[66] M. Knopp,et al. Alterations of intratumoral pharmacokinetics of 5-fluorouracil in head and neck carcinoma during simultaneous radiochemotherapy. , 1999, Cancer research.
[67] Julien Valette,et al. Long-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRI. , 2012, Biomaterials.
[68] T. Hitchens,et al. Imaging Neuroinflammation In Vivo in a Neuropathic Pain Rat Model with Near-Infrared Fluorescence and 19F Magnetic Resonance , 2014, PloS one.
[69] E. McVeigh,et al. Signal‐to‐noise ratio behavior of steady‐state free precession , 2004, Magnetic resonance in medicine.
[70] Correction of chemical‐shift artifacts in 19F imaging of PFOB: A robust signed magnitude method , 1992, Magnetic resonance in medicine.
[71] P. Heusch,et al. Visualization of immune cell infiltration in experimental viral myocarditis by 19F MRI in vivo , 2014, Magnetic Resonance Materials in Physics, Biology and Medicine.
[72] Jürgen Hennig,et al. Revealing signal from noisy 19F MR images by chemical shift artifact correction , 2015, Magnetic resonance in medicine.
[73] R. Buxton,et al. The use of Imagent BP in diagnostic imaging research and 19F magnetic resonance for PO2 measurements. , 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.
[74] N. Gavriely,et al. Influence of intravenous perfluorocarbon administration on the dynamic behavior of lung surfactant. , 1998, Artificial cells, blood substitutes, and immobilization biotechnology.
[75] Samuel A Wickline,et al. Variable Antibody-dependent Activation of Complement by Functionalized Phospholipid Nanoparticle Surfaces* , 2010, The Journal of Biological Chemistry.
[76] S. Caruthers,et al. Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3‐integrin‐targeted nanoparticles , 2010, Magnetic resonance in medicine.
[77] Nirbhay N. Yadav,et al. Monitoring enzyme activity using a diamagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. , 2011, Journal of the American Chemical Society.
[78] Samuel A. Wickline,et al. Perfluorocarbon Nanoemulsions for Quantitative Molecular Imaging and Targeted Therapeutics , 2009, Annals of Biomedical Engineering.
[79] E. Ahrens,et al. Visualizing arthritic inflammation and therapeutic response by fluorine-19 magnetic resonance imaging (19F MRI) , 2012, Journal of Inflammation.
[80] J. G. Miller,et al. High-frequency ultrasonic detection of thrombi with a targeted contrast system. , 1997, Ultrasound in medicine & biology.
[81] S. Flaim. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.
[82] E. Terreno,et al. Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents. , 2008, Chemical communications.
[83] P. Schlesinger,et al. Synthesis and characterization of stable fluorocarbon nanostructures as drug delivery vehicles for cytolytic peptides. , 2008, Nano letters.
[84] K. Gilbert,et al. In vivo MR detection of fluorine-labeled human MSC using the bSSFP sequence , 2014, International journal of nanomedicine.
[85] E. Terreno,et al. Methods for an improved detection of the MRI-CEST effect. , 2009, Contrast media & molecular imaging.
[86] Robert E Lenkinski,et al. On-resonance low B1 pulses for imaging of the effects of PARACEST agents. , 2005, Journal of magnetic resonance.
[87] I. Kuprov,et al. Lanthanide Complexes as Paramagnetic Probes for 19F Magnetic Resonance , 2012 .
[88] Samuel A. Wickline,et al. Endothelial &agr;&ngr;&bgr;3 Integrin–Targeted Fumagillin Nanoparticles Inhibit Angiogenesis in Atherosclerosis , 2006 .
[89] Gultekin Gulsen,et al. Automatic tuned MRI RF coil for multinuclear imaging of small animals at 3T. , 2002, Journal of magnetic resonance.
[90] Shelton D Caruthers,et al. Intramural Delivery of Rapamycin With &agr;v&bgr;3-Targeted Paramagnetic Nanoparticles Inhibits Stenosis After Balloon Injury , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[91] J. Modell,et al. Long-term survival of dogs after breathing oxygenated fluorocarbon liquid. , 1970, Federation proceedings.
[92] S E Seltzer,et al. In vivo 19F NMR imaging of liver, tumor, and abscess in rats. Preliminary results. , 1985, Investigative radiology.
[93] P. Antich,et al. A noninvasive assessment of myocardial oxygen tension: 19f nmr spectroscopy of sequestered perfluorocarbon emulsion , 1992, Magnetic resonance in medicine.
[94] Rolf Schubert,et al. Probing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half‐lives and sensitivity , 2014, NMR in biomedicine.
[95] Mangala Srinivas,et al. Self-delivering nanoemulsions for dual fluorine-19 MRI and fluorescence detection. , 2008, Journal of the American Chemical Society.
[96] D. Hirst,et al. Detection of acute radiation damage to the spleen in mice by using fluorine-19 MR imaging. , 1988, AJR. American journal of roentgenology.
[97] L. Juhlin. Excretion of intravenously injected solid particles in bile. , 1960, Acta physiologica Scandinavica.
[98] S. Caruthers,et al. 19 F/ 1 H Simultaneous 3D Radial Imaging of Atherosclerotic Rabbits Using Self-Navigated Respiratory Motion Compensation , 2009 .
[99] S. Curtis,et al. Partial liquid breathing with perflubron improves arterial oxygenation in acute canine lung injury. , 1993, Journal of applied physiology.
[100] S. Wickline,et al. Thrombin‐inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis , 2011, Journal of thrombosis and haemostasis : JTH.
[101] Robert E Lenkinski,et al. CEST: from basic principles to applications, challenges and opportunities. , 2013, Journal of magnetic resonance.
[102] J A Frank,et al. Imaging macrophage activity in the brain by using ultrasmall particles of iron oxide. , 2000, AJNR. American journal of neuroradiology.
[103] Paul A. Bottomley,et al. 19F magnetic resonance imaging , 1977 .
[104] M. André,et al. Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs. , 1984, The American journal of cardiology.
[105] Tobias Schaeffter,et al. Simultaneous dual‐nuclei imaging for motion corrected detection and quantification of 19F imaging agents , 2011, Magnetic resonance in medicine.
[106] Shelton D Caruthers,et al. Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agents. , 2007, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[107] S. Caruthers,et al. Characterization of early neovascular response to acute lung ischemia using simultaneous 19F/1H MR molecular imaging , 2013, Angiogenesis.
[108] L. J. Busse,et al. Deconvolution of chemical shift spectra in two- or three-dimensional [19F] MR imaging. , 1988, Journal of computer assisted tomography.
[109] R. Mattrey,et al. Preparation and application of highly concentrated perfluoroctylbromide fluorocarbon emulsions. , 1988, Biomaterials, artificial cells, and artificial organs.
[110] S. Caruthers,et al. Three‐dimensional MR mapping of angiogenesis with α5β1(αvβ3)‐targeted theranostic nanoparticles in the MDA‐MB‐435 xenograft mouse model , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[111] A. Sherry,et al. Europium(III) DOTA-tetraamide complexes as redox-active MRI sensors. , 2012, Journal of the American Chemical Society.
[112] Shelton D Caruthers,et al. Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. , 2008, JACC. Cardiovascular imaging.
[113] E. Ahrens,et al. Clinical cell therapy imaging using a perfluorocarbon tracer and fluorine-19 MRI , 2014, Magnetic resonance in medicine.
[114] Mangala Srinivas,et al. Fluorine‐19 MRI for visualization and quantification of cell migration in a diabetes model , 2007, Magnetic resonance in medicine.
[115] Eric T Ahrens,et al. Accelerated fluorine‐19 MRI cell tracking using compressed sensing , 2013, Magnetic resonance in medicine.
[116] H. Hummler,et al. Preserved spontaneous breathing improves cardiac output during partial liquid ventilation. , 2001, American journal of respiratory and critical care medicine.
[117] Samuel A Wickline,et al. In vivo “hot spot” MR imaging of neural stem cells using fluorinated nanoparticles , 2008, Magnetic resonance in medicine.
[118] J. Connett,et al. Dynamics of spontaneous breathing during patient‐triggered partial liquid ventilation , 1998, Pediatric pulmonology.
[119] J. Bulte,et al. New “multicolor” polypeptide diamagnetic chemical exchange saturation transfer (DIACEST) contrast agents for MRI , 2008, Magnetic resonance in medicine.
[120] J. Bulte,et al. Tracking immune cells in vivo using magnetic resonance imaging , 2013, Nature Reviews Immunology.
[121] F. Hyder,et al. A lanthanide complex with dual biosensing properties: CEST (chemical exchange saturation transfer) and BIRDS (biosensor imaging of redundant deviation in shifts) with europium DOTA–tetraglycinate , 2011, NMR in biomedicine.
[122] E. Ahrens,et al. Fluorine-containing nanoemulsions for MRI cell tracking. , 2009, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.
[123] Rolf Schubert,et al. In Vivo Monitoring of Inflammation After Cardiac and Cerebral Ischemia by Fluorine Magnetic Resonance Imaging , 2008, Circulation.
[124] Richard A. Guyer,et al. Optimization of scan parameters in pulmonary partial pressure oxygen measurement by hyperpolarized 3He MRI , 2008, Magnetic resonance in medicine.
[125] C. Higgins,et al. Specific enhancement of intra-abdominal abscesses with perfluoroctylbromide for CT imaging. , 1983, Investigative radiology.
[126] M. Neeman,et al. Cardio-Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Reveals Molecular Signatures of Endogenous Fibrosis and Exogenous Contrast Media , 2014, Circulation. Cardiovascular imaging.
[127] R. J. Kaufman. Clinical Development of Perfluorocarbon-based Emulsions as Red Cell Substitutes , 1995 .
[128] Shelton D Caruthers,et al. Targeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRI , 2004, Magnetic resonance in medicine.
[129] Giuseppe Baselli,et al. Optimization of rapid acquisition with relaxation enhancement (RARE) pulse sequence parameters for 19F‐MRI studies , 2014, Journal of magnetic resonance imaging : JMRI.
[130] D. Sartoris,et al. Perfluoroctylbromide as a contrast agent for computed tomographic imaging of septic and aseptic arthritis. , 1986, Investigative radiology.
[131] A J Colon. MR findings of the brain stem in arterial hypertension. , 2000, AJNR. American journal of neuroradiology.
[132] J. G. Miller,et al. A novel site-targeted ultrasonic contrast agent with broad biomedical application. , 1996, Circulation.
[133] Grace Hu,et al. Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles , 2005, Magnetic resonance in medicine.
[134] S. Mériaux,et al. RGD decoration of PEGylated polyester nanocapsules of perfluorooctyl bromide for tumor imaging: influence of pre or post-functionalization on capsule morphology. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[135] Enzo Terreno,et al. A paramagnetic MRI-CEST agent responsive to lactate concentration. , 2002, Journal of the American Chemical Society.
[136] Piotr Walczak,et al. Artificial reporter gene providing MRI contrast based on proton exchange , 2007, Nature Biotechnology.
[137] A. Kassner,et al. Assessment of tumor angiogenesis: dynamic contrast-enhanced MRI with paramagnetic nanoparticles compared with Gd-DTPA in a rabbit Vx-2 tumor model. , 2010, Contrast media & molecular imaging.
[138] R. Brooks,et al. T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): theory and experiment. , 1998, Academic radiology.
[139] H. Ohyanagi,et al. Clinical studies of a perfluorochemical whole blood substitute (Fluosol-DA) Summary of 186 cases. , 1982, Annals of surgery.
[140] C. Sotak,et al. Detection of Tumors with 19F Magnetic Resonance Imaging , 1988, Investigative radiology.
[141] A Dean Sherry,et al. Synthesis and Characterization of DOTA-(amide)(4) Derivatives: Equilibrium and Kinetic Behavior of Their Lanthanide(III) Complexes. , 2007, European journal of inorganic chemistry.
[142] S. Caruthers,et al. Rapid quantification of oxygen tension in blood flow with a fluorine nanoparticle reporter and a novel blood flow‐enhanced‐saturation‐recovery sequence , 2013, Magnetic resonance in medicine.
[143] W. Mitzner,et al. Angiogenesis and airway reactivity in asthmatic Brown Norway rats , 2014, Angiogenesis.
[144] M. Viergever,et al. Magnetic Resonance Imaging of Monocytes Labeled with Ultrasmall Superparamagnetic Particles of Iron Oxide Using Magnetoelectroporation in an Animal Model of Multiple Sclerosis , 2010, Molecular imaging.
[145] S A Wickline,et al. Novel MRI Contrast Agent for Molecular Imaging of Fibrin: Implications for Detecting Vulnerable Plaques , 2001, Circulation.
[146] E. Ahrens,et al. Functional assessment of human dendritic cells labeled for in vivo (19)F magnetic resonance imaging cell tracking. , 2010, Cytotherapy.
[147] S. Caruthers,et al. Gadolinium‐modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging , 2008, Magnetic resonance in medicine.
[148] Garry E. Kiefer,et al. Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles , 2007 .
[149] R. Mattrey,et al. Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging. , 1989, AJR. American journal of roentgenology.
[150] W Wolf,et al. 19F-MRS studies of fluorinated drugs in humans. , 2000, Advanced drug delivery reviews.
[151] Jürgen Rahmer,et al. Balanced UTE‐SSFP for 19F MR imaging of complex spectra , 2015, Magnetic resonance in medicine.
[152] J. Werkmeister,et al. MR three-dimensional molecular imaging of intramural biomarkers with targeted nanoparticles. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[153] Robert E Lenkinski,et al. PARACEST agents: modulating MRI contrast via water proton exchange. , 2003, Accounts of chemical research.
[154] F. Franconi,et al. Perfluorocarbon-loaded lipid nanocapsules as oxygen sensors for tumor tissue pO₂ assessment. , 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[155] O. Togao,et al. Off-resonance saturation MRI of superparamagnetic nanoprobes: theoretical models and experimental validations. , 2011, Journal of magnetic resonance.
[156] Shelton D Caruthers,et al. Simultaneous Dual Frequency $^{1}{\rm H}$ and $^{19}{\rm F}$ Open Coil Imaging of Arthritic Rabbit Knee at 3T , 2011, IEEE Transactions on Medical Imaging.
[157] Jinyuan Zhou,et al. Quantifying exchange rates in chemical exchange saturation transfer agents using the saturation time and saturation power dependencies of the magnetization transfer effect on the magnetic resonance imaging signal (QUEST and QUESP): Ph calibration for poly‐L‐lysine and a starburst dendrimer , 2006, Magnetic resonance in medicine.
[158] Shelton D Caruthers,et al. Improved quantitative 19F MR molecular imaging with flip angle calibration and B1‐mapping compensation , 2015, Journal of magnetic resonance imaging : JMRI.
[159] Shelton D Caruthers,et al. Molecular imaging of human thrombus with computed tomography. , 2005, Academic radiology.
[160] J. Arbeit,et al. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. , 2009, The Journal of clinical investigation.
[161] J. G. Miller,et al. In vitro characterization of a novel, tissue-targeted ultrasonic contrast system with acoustic microscopy. , 1998, The Journal of the Acoustical Society of America.
[162] R. Razavi,et al. Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[163] J. Bulte,et al. Magnetization transfer contrast MRI for non-invasive assessment of innate and adaptive immune responses against alginate-encapsulated cells. , 2014, Biomaterials.
[164] J. Riess,et al. Perfluoro compounds as blood substitutes. , 1978, Angewandte Chemie.
[165] Geyer Rp. Bloodless" rats through the use of artificial blood substitutes. , 1975 .
[166] S. Caruthers,et al. A fibrin-specific thrombolytic nanomedicine approach to acute ischemic stroke. , 2011, Nanomedicine.
[167] R.L. Magin,et al. A simple method to incorporate the effects of an RF shield into RF resonator analysis for MRI applications , 1995, IEEE Transactions on Biomedical Engineering.
[168] Takesada Mori,et al. Tumor imaging with anti‐CEA antibody labeled 19F emulsion , 1987, Magnetic resonance in medicine.
[169] A Haase,et al. 19F‐MRI in vivo determination of the partial oxygen pressure in perfluorocarbon‐loaded alginate capsules implanted into the peritoneal cavity and different tissues , 1999, Magnetic resonance in medicine.
[170] J. Bulte,et al. Magnetic intracellular labeling of mammalian cells by combining (FDA-approved) superparamagnetic iron oxide MR contrast agents and commonly used transfection agents. , 2002, Academic radiology.
[171] T. Niendorf,et al. Eight‐channel transceiver RF coil array tailored for 1H/19F MR of the human knee and fluorinated drugs at 7.0 T , 2015, NMR in biomedicine.
[172] E. Terreno,et al. Osmotically shrunken LIPOCEST agents: an innovative class of magnetic resonance imaging contrast media based on chemical exchange saturation transfer. , 2009, Chemistry.
[173] Eric T Ahrens,et al. In vivo imaging platform for tracking immunotherapeutic cells , 2005, Nature Biotechnology.
[174] A. Sherry,et al. Gd3+ Complexes with Slowly Exchanging Bound-Water Molecules May Offer Advantages in the Design of Responsive MR Agents , 2001, Investigative radiology.
[175] Kirk D. Wallace,et al. Simultaneous Dual Frequency 1H and 19F Open Coil Imaging of Arthritic Rabbit Knee at 3T , 2011, IEEE Trans. Medical Imaging.
[176] P. Z. Sun,et al. A General MRI-CEST Ratiometric Approach for pH Imaging: Demonstration of in Vivo pH Mapping with Iobitridol , 2014, Journal of the American Chemical Society.
[177] Xiaolei Song,et al. CEST phase mapping using a length and offset varied saturation (LOVARS) scheme , 2012, Magnetic resonance in medicine.
[178] S. Caruthers,et al. Minute dosages of ανβ3‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[179] S. Caruthers,et al. MR molecular imaging of aortic angiogenesis. , 2010, JACC. Cardiovascular imaging.
[180] Jeff W M Bulte,et al. Monitoring cell therapy using iron oxide MR contrast agents. , 2004, Current pharmaceutical biotechnology.
[181] Lei Zhang,et al. A generalized strategy for designing 19F/1H dual‐frequency MRI coil for small animal imaging at 4.7 Tesla , 2011, Journal of magnetic resonance imaging : JMRI.
[182] Piotr Walczak,et al. Use of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic islets. , 2011, Contrast media & molecular imaging.
[183] J. Bulte,et al. MR cholangiography demonstrates unsuspected rapid biliary clearance of nanoparticles in rodents: implications for clinical translation. , 2014, Nanomedicine : nanotechnology, biology, and medicine.